Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T Cells Against HLA Loss Leukemia Relapses

Pier Edoardo Rovatti, MD, Laura Zito, MSc, Eleonora Draghi, MSc, Monika Herrmann, PhD, Anetta Marcinek, MSc, Bettina Brauchle, MSc, Cesare Covino, MSc, Mattia Di Bono, MSc, Matteo Giovanni Carrabba, MD, Massimo Bernardi, MD, Karl-Peter Hopfner, PhD, Cristina Toffalori, PhD, Fabio Ciceri, MD, Marion Subklewe, MD, Luca Vago, MD PhD

Blood (2019) 134 (Supplement_1): 513.

https://doi.org/10.1182/blood-2019-126641

Published: 2019

Journal Articles

Integrated Epigenetic Profiling Identifies EZH2 As a Therapeutic Target to Re-Establish Immune Recognition of Leukemia Relapses with Loss of HLA Class II Expression

Valentina Gambacorta, MSc, Daniela Gnani, PhD, Laura Zito, MSc, Stefano Beretta, PhD, Lucia Zanotti, PhD, Oliveira Giacomo, PhD, Davide Cittaro, PhD, Ivan Merelli, PhD, Fabio Ciceri, MD, Raffaella Di Micco, PhD, Luca Vago, MD PhD

Blood (2019) 134 (Supplement_1): 514.

https://doi.org/10.1182/blood-2019-127395

Published: 2019

Journal Articles

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Lucia Zanotti, PhD, Gabriele Bucci, PhD, Francesco Santaniello, Cristina Toffalori, Donatella Biancolini, PhD, Ettore Zapparoli, Laura Zito, Matteo Giovanni Carrabba, MD, Friedrich Stoelzel, Martin Bornhäuser, Massimo Bernardi, MD, Jacopo Peccatori, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, Giovanni Tonon, MD PhD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2018) 132 (Supplement 1): 819.

https://doi.org/10.1182/blood-2018-99-111769

Published: 2018

Journal Articles

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications

Antonio Russo, Giacomo Oliveira, Sofia Berglund, Raffaella Greco, Valentina Gambacorta, Nicoletta Cieri, Cristina Toffalori, Laura Zito, Francesca Lorentino, Simona Piemontese, Mara Morelli, Fabio Giglio, Andrea Assanelli, Maria Teresa Lupo Stanghellini, Chiara Bonini, Jacopo Peccatori, Fabio Ciceri, Leo Luznik, Luca Vago

Blood (2018) 131 (2): 247–262.

https://doi.org/10.1182/blood-2017-05-780668

Published: 2018

Includes: Supplemental data

Journal Articles

Natural Killer Cell Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide: Elimination of Donor-Derived Mature Alloreactive NK Cells, but Favorable Conditions for Adoptive Immunotherapy

Antonio Russo, Giacomo Oliveira, PhD, Sofia Berglund, MD PhD, Raffaella Greco, MD, Valentina Gambacorta, MSc, Nicoletta Cieri, MD PhD, Cristina Toffalori, PhD, Laura Zito, MSc, Simona Piemontese, MD, Mara Morelli, MD, Fabio Giglio, MD, Andrea Angelo Assanelli, MD, Maria Teresa Lupo Stanghellini, MD, Chiara Bonini, MD, Jacopo Peccatori, MD, Leo Luznik, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2016) 128 (22): 4567.

https://doi.org/10.1182/blood.V128.22.4567.4567

Published: 2016

Journal Articles

Clinical and Biological Features Associated with Engraftment of Acute Myeloid Leukemia Patient-Derived Xenografts

Giacomo Oliveira, PhD, Gabriele Bucci, PhD, Cristina Toffalori, PhD, Carolina Caserta, Lara Crucitti, MD, Barbara Camisa, BSc, Raffaella Greco, MD, Francesca Biavasco, Lucia Zanotti, PhD, Laura Zito, MSc, Jose Manuel Garcia-Manteiga, PhD, Dejan Lazarevic, MD, Matteo Giovanni Carrabba, MD, Massimo Bernardi, MD, Attilio Bondanza, MD PhD, Chiara Bonini, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2016) 128 (22): 2858.

https://doi.org/10.1182/blood.V128.22.2858.2858

Published: 2016

Journal Articles

HLA Loss Leukemia Relapses after Partially-Incompatible Allogeneic HSCT As a Prototypical System to Investigate Natural Killer Cell Dynamics

Valentina Gambacorta, MSc, Giacomo Oliveira, PhD, Laura Zito, MSc, Cristina Toffalori, PhD, Lara Crucitti, MD, Maddalena Noviello, PhD, Benedetta Mazzi, MSc, Raffaella Greco, MD, Maria Teresa Lupo Stanghellini, MD, Matteo G Carrabba, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Katharina Fleischhauer, MD, Chiara Bonini, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2015) 126 (23): 743.

https://doi.org/10.1182/blood.V126.23.743.743

Published: 2015

Journal Articles

Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation

Cristina Toffalori, PhD, Michela Riba, PhD, Laura Zito, BSc, Matteo Barcella, MSc, Orietta Spinelli, PhD, Lara Crucitti, MD, Nicoletta Cieri, MD PhD, Jacopo Peccatori, MD, Massimo Bernardi, MD, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Alessandro Rambaldi, Cristina Barlassina, BSc, Elia Stupka, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Luca Vago, MD PhD

Blood (2014) 124 (21): 427.

https://doi.org/10.1182/blood.V124.21.427.427

Published: 2014

Journal Articles

Significantly higher frequencies of alloreactive CD4 + T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities

Federico Sizzano, Laura Zito, Pietro Crivello, Roberto Crocchiolo, Luca Vago, Elisabetta Zino, Katharina Fleischhauer

Blood (2010) 116 (11): 1991–1992.

https://doi.org/10.1182/blood-2010-05-284687

Published: 2010

Journal Articles

Optimal Thalassemia Free Survival and Minimal Regimen Related Toxicity in 50 Consecutive Transplants of High Risk Beta Thalassemia Pediatric Patients Using Myelablative Therapy with Intravenous Busulphan.

Blood (2008) 112 (11): 3266.

https://doi.org/10.1182/blood.V112.11.3266.3266

Published: 2008

NARROW

Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T Cells Against HLA Loss Leukemia Relapses

Integrated Epigenetic Profiling Identifies EZH2 As a Therapeutic Target to Re-Establish Immune Recognition of Leukemia Relapses with Loss of HLA Class II Expression

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications

Natural Killer Cell Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide: Elimination of Donor-Derived Mature Alloreactive NK Cells, but Favorable Conditions for Adoptive Immunotherapy

Clinical and Biological Features Associated with Engraftment of Acute Myeloid Leukemia Patient-Derived Xenografts

HLA Loss Leukemia Relapses after Partially-Incompatible Allogeneic HSCT As a Prototypical System to Investigate Natural Killer Cell Dynamics

Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation

Significantly higher frequencies of alloreactive CD4 + T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities

Optimal Thalassemia Free Survival and Minimal Regimen Related Toxicity in 50 Consecutive Transplants of High Risk Beta Thalassemia Pediatric Patients Using Myelablative Therapy with Intravenous Busulphan.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only